Focuses on arrhythmogenic cardiomyopathy from mechanism to therapy: integrating cardiac electrophysiology, molecular pathology, and systems physiology with imaging and computational analysis. Uses patient-derived cells, organoids, and animal models to map fibrosis-conduction coupling, stratify risk, and test disease-modifying therapies.